Identification of molecular targets for the targeted treatment of gastric cancer using dasatinib

Gastric cancer (GC) remains the third leading cause of cancer-related death despite several improvements in targeted therapy. There is therefore an urgent need to investigate new treatment strategies, including the identification of novel biomarkers for patient stratification. In this study, we eval...

Descripción completa

Detalles Bibliográficos
Autores principales: Montenegro, Raquel Carvalho, Howarth, Alison, Ceroni, Alessandro, Fedele, Vita, Farran, Batoul, Mesquita, Felipe Pantoja, Frejno, Martin, Berger, Benedict-Tilman, Heinzlmeir, Stephanie, Sailem, Heba Z., Tesch, Roberta, Ebner, Daniel, Knapp, Stefan, Burbano, Rommel, Kuster, Bernhard, Müller, Susanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7007292/
https://www.ncbi.nlm.nih.gov/pubmed/32082487
http://dx.doi.org/10.18632/oncotarget.27462

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7007292/
https://www.ncbi.nlm.nih.gov/pubmed/32082487
http://dx.doi.org/10.18632/oncotarget.27462

Ejemplares similares